DK2968467T3 - Formuleringer med reduceret oxidation - Google Patents
Formuleringer med reduceret oxidation Download PDFInfo
- Publication number
- DK2968467T3 DK2968467T3 DK14776479.9T DK14776479T DK2968467T3 DK 2968467 T3 DK2968467 T3 DK 2968467T3 DK 14776479 T DK14776479 T DK 14776479T DK 2968467 T3 DK2968467 T3 DK 2968467T3
- Authority
- DK
- Denmark
- Prior art keywords
- formulations
- reduced oxidation
- oxidation
- reduced
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361780852P | 2013-03-13 | 2013-03-13 | |
US201361909850P | 2013-11-27 | 2013-11-27 | |
PCT/US2014/026850 WO2014160497A1 (en) | 2013-03-13 | 2014-03-13 | Formulations with reduced oxidation |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2968467T3 true DK2968467T3 (da) | 2020-08-10 |
Family
ID=51625443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14776479.9T DK2968467T3 (da) | 2013-03-13 | 2014-03-13 | Formuleringer med reduceret oxidation |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP2968467B1 (da) |
JP (2) | JP6606059B2 (da) |
KR (2) | KR102238379B1 (da) |
CN (1) | CN105209058A (da) |
BR (1) | BR112015022475A8 (da) |
CA (2) | CA2904169C (da) |
DK (1) | DK2968467T3 (da) |
ES (1) | ES2808823T3 (da) |
HK (1) | HK1212613A1 (da) |
HR (1) | HRP20201161T1 (da) |
HU (1) | HUE049707T2 (da) |
LT (1) | LT2968467T (da) |
MX (1) | MX370416B (da) |
PL (1) | PL2968467T3 (da) |
PT (1) | PT2968467T (da) |
RS (1) | RS60534B1 (da) |
RU (2) | RU2707550C2 (da) |
SI (1) | SI2968467T1 (da) |
WO (1) | WO2014160497A1 (da) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114699525A (zh) * | 2015-08-18 | 2022-07-05 | 乐天医药生技股份有限公司 | 酞菁染料偶联物的制造方法及稳定偶联物 |
CA2994849A1 (en) | 2015-08-18 | 2017-02-23 | Aspyrian Therapeutics, Inc. | Compositions, combinations and related methods for photoimmunotherapy |
EP3833389A1 (en) | 2018-08-08 | 2021-06-16 | Genentech, Inc. | Use of tryptophan derivatives and l-methionine for protein formulation |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
US4419446A (en) | 1980-12-31 | 1983-12-06 | The United States Of America As Represented By The Department Of Health And Human Services | Recombinant DNA process utilizing a papilloma virus DNA as a vector |
NZ201705A (en) | 1981-08-31 | 1986-03-14 | Genentech Inc | Recombinant dna method for production of hepatitis b surface antigen in yeast |
US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
DD266710A3 (de) | 1983-06-06 | 1989-04-12 | Ve Forschungszentrum Biotechnologie | Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase |
US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
US4965199A (en) | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
US4879231A (en) | 1984-10-30 | 1989-11-07 | Phillips Petroleum Company | Transformation of yeasts of the genus pichia |
GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
US6548640B1 (en) | 1986-03-27 | 2003-04-15 | Btg International Limited | Altered antibodies |
US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
GB8610600D0 (en) | 1986-04-30 | 1986-06-04 | Novo Industri As | Transformation of trichoderma |
EP0435911B1 (en) | 1988-09-23 | 1996-03-13 | Cetus Oncology Corporation | Cell culture medium for enhanced cell growth, culture longevity and product expression |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
JP2919890B2 (ja) | 1988-11-11 | 1999-07-19 | メディカル リサーチ カウンスル | 単一ドメインリガンド、そのリガンドからなる受容体、その製造方法、ならびにそのリガンドおよび受容体の使用 |
FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
EP0402226A1 (en) | 1989-06-06 | 1990-12-12 | Institut National De La Recherche Agronomique | Transformation vectors for yeast yarrowia |
DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
EP0739904A1 (en) | 1989-06-29 | 1996-10-30 | Medarex, Inc. | Bispecific reagents for aids therapy |
US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
DE69133566T2 (de) | 1990-01-12 | 2007-12-06 | Amgen Fremont Inc. | Bildung von xenogenen Antikörpern |
US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
US6075181A (en) | 1990-01-12 | 2000-06-13 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
EP0547065B1 (en) | 1990-06-29 | 2001-08-29 | Large Scale Biology Corporation | Melanin production by transformed microorganisms |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
DK0814159T3 (da) | 1990-08-29 | 2005-10-24 | Genpharm Int | Transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer |
US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
WO1992009690A2 (en) | 1990-12-03 | 1992-06-11 | Genentech, Inc. | Enrichment method for variant proteins with altered binding properties |
US5571894A (en) | 1991-02-05 | 1996-11-05 | Ciba-Geigy Corporation | Recombinant antibodies specific for a growth factor receptor |
GB9114948D0 (en) | 1991-07-11 | 1991-08-28 | Pfizer Ltd | Process for preparing sertraline intermediates |
JP3951062B2 (ja) | 1991-09-19 | 2007-08-01 | ジェネンテック・インコーポレーテッド | 少なくとも遊離のチオールとして存在するシステインを有する抗体フラグメントの大腸菌での発現、2官能性F(ab’)2抗体の産生のための使用 |
DK0605522T3 (da) | 1991-09-23 | 2000-01-17 | Medical Res Council | Fremgangsmåde til fremstilling af humaniserede antistoffer |
US5587458A (en) | 1991-10-07 | 1996-12-24 | Aronex Pharmaceuticals, Inc. | Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof |
WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
US5667988A (en) | 1992-01-27 | 1997-09-16 | The Scripps Research Institute | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
ATE295420T1 (de) | 1992-02-06 | 2005-05-15 | Chiron Corp | Marker für krebs und biosynthetisches bindeprotein dafür |
CA2140280A1 (en) | 1992-08-17 | 1994-03-03 | Avi J. Ashkenazi | Bispecific immunoadhesins |
PT752248E (pt) | 1992-11-13 | 2001-01-31 | Idec Pharma Corp | Aplicacao terapeutica de anticorpos quimericos e marcados radioactivamente contra antigenios de diferenciacao restrita de linfocitos b humanos para o tratamento do linfoma de celulas b |
US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
US5869046A (en) | 1995-04-14 | 1999-02-09 | Genentech, Inc. | Altered polypeptides with increased half-life |
EP0822830B1 (en) | 1995-04-27 | 2008-04-02 | Amgen Fremont Inc. | Human anti-IL-8 antibodies, derived from immunized xenomice |
AU2466895A (en) | 1995-04-28 | 1996-11-18 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
RU2134120C1 (ru) * | 1995-06-26 | 1999-08-10 | Безруков Михаил Васильевич | Средство для стабилизации пептидной связи в белковом препарате |
EP0921855B1 (en) | 1996-08-30 | 2003-11-19 | Upfront Chromatography A/S | Isolation of immunoglobulins |
CA2722378C (en) | 1996-12-03 | 2015-02-03 | Amgen Fremont Inc. | Human antibodies that bind tnf.alpha. |
US20080318254A9 (en) | 1997-03-10 | 2008-12-25 | The Regents Of The University Of California | PSCA antibodies and hybridomas producing them |
US20020173629A1 (en) | 1997-05-05 | 2002-11-21 | Aya Jakobovits | Human monoclonal antibodies to epidermal growth factor receptor |
US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
US6610833B1 (en) | 1997-11-24 | 2003-08-26 | The Institute For Human Genetics And Biochemistry | Monoclonal human natural antibodies |
PT1034298E (pt) | 1997-12-05 | 2012-02-03 | Scripps Research Inst | Humanização de anticorpo murino |
JP2000247903A (ja) * | 1999-03-01 | 2000-09-12 | Chugai Pharmaceut Co Ltd | 長期安定化製剤 |
DE60039596D1 (de) | 1999-03-30 | 2008-09-04 | Japan Tobacco Inc | Verfahren zur herstellung von monoklonalen antikörpern |
US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
CA2385347C (en) | 1999-10-04 | 2009-12-15 | Medicago Inc. | Method for regulating transcription of foreign genes |
CN100389821C (zh) * | 1999-10-04 | 2008-05-28 | 希龙公司 | 稳定化的含多肽的液体药物组合物 |
JP2001165858A (ja) * | 1999-12-06 | 2001-06-22 | Bunshi Biophotonics Kenkyusho:Kk | 5−アルコキシインドール類の測定方法及び装置 |
JP2005519580A (ja) | 2001-05-16 | 2005-07-07 | アルバート アインシュタイン カレッジ オブ メディシン オブ イエシバ ユニバーシティ | 非ヒト動物由来のヒト抗肺炎球菌抗体 |
PT1425389E (pt) | 2001-08-23 | 2012-02-07 | Genmab As | Anticorpos humanos específicos para interleucina 15 (il-15) |
AU2003251906B2 (en) * | 2002-07-12 | 2008-12-04 | Medarex, Inc. | Methods and compositions for preventing oxidative degradation of proteins |
AU2004205898B2 (en) | 2003-01-17 | 2009-11-19 | The Research Foundation Of State University Of New York | Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
US20060104968A1 (en) | 2003-03-05 | 2006-05-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases |
US7871607B2 (en) | 2003-03-05 | 2011-01-18 | Halozyme, Inc. | Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases |
CA2526398C (en) | 2003-05-21 | 2014-07-15 | Medarex, Inc. | Human monoclonal antibodies against bacillus anthracis protective antigen |
CN101074208A (zh) * | 2007-06-29 | 2007-11-21 | 方炳良 | 吲哚衍生物的制备方法 |
RU2414237C2 (ru) * | 2008-04-30 | 2011-03-20 | Государственное образовательное учреждение высшего профессионального образования "Удмуртский государственный университет" | Модификация альбумина совиалем как способ повышения его стабильности для производства фармацевтического биопрепарата альбумина в комплексе с гентамицином или стимаденом |
US20100068210A1 (en) * | 2008-09-10 | 2010-03-18 | Ji Junyan A | Compositions and methods for the prevention of oxidative degradation of proteins |
MX369671B (es) * | 2013-03-13 | 2019-11-15 | Genentech Inc | Formulaciones con oxidacion reducida. |
-
2014
- 2014-03-13 RU RU2015143549A patent/RU2707550C2/ru active
- 2014-03-13 PL PL14776479T patent/PL2968467T3/pl unknown
- 2014-03-13 EP EP14776479.9A patent/EP2968467B1/en active Active
- 2014-03-13 DK DK14776479.9T patent/DK2968467T3/da active
- 2014-03-13 PT PT147764799T patent/PT2968467T/pt unknown
- 2014-03-13 JP JP2016502264A patent/JP6606059B2/ja active Active
- 2014-03-13 ES ES14776479T patent/ES2808823T3/es active Active
- 2014-03-13 CA CA2904169A patent/CA2904169C/en active Active
- 2014-03-13 RS RS20200848A patent/RS60534B1/sr unknown
- 2014-03-13 KR KR1020157027939A patent/KR102238379B1/ko active IP Right Grant
- 2014-03-13 CN CN201480027210.8A patent/CN105209058A/zh active Pending
- 2014-03-13 HU HUE14776479A patent/HUE049707T2/hu unknown
- 2014-03-13 RU RU2019137020A patent/RU2019137020A/ru unknown
- 2014-03-13 LT LTEP14776479.9T patent/LT2968467T/lt unknown
- 2014-03-13 CA CA3135558A patent/CA3135558A1/en not_active Abandoned
- 2014-03-13 KR KR1020217009995A patent/KR102317151B1/ko active IP Right Grant
- 2014-03-13 SI SI201431625T patent/SI2968467T1/sl unknown
- 2014-03-13 MX MX2015011433A patent/MX370416B/es active IP Right Grant
- 2014-03-13 WO PCT/US2014/026850 patent/WO2014160497A1/en active Application Filing
- 2014-03-13 BR BR112015022475A patent/BR112015022475A8/pt not_active Application Discontinuation
-
2016
- 2016-01-20 HK HK16100589.9A patent/HK1212613A1/zh unknown
-
2019
- 2019-05-08 JP JP2019088239A patent/JP2019167349A/ja active Pending
-
2020
- 2020-07-24 HR HRP20201161TT patent/HRP20201161T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
PT2968467T (pt) | 2020-07-28 |
KR20210040190A (ko) | 2021-04-12 |
ES2808823T3 (es) | 2021-03-02 |
JP2019167349A (ja) | 2019-10-03 |
MX2015011433A (es) | 2016-04-27 |
CN105209058A (zh) | 2015-12-30 |
RU2015143549A (ru) | 2017-04-20 |
RU2019137020A (ru) | 2021-01-14 |
EP2968467B1 (en) | 2020-06-03 |
WO2014160497A1 (en) | 2014-10-02 |
CA3135558A1 (en) | 2014-10-02 |
HK1212613A1 (zh) | 2016-06-17 |
RS60534B1 (sr) | 2020-08-31 |
LT2968467T (lt) | 2020-08-25 |
EP2968467A4 (en) | 2016-09-21 |
JP6606059B2 (ja) | 2019-11-13 |
BR112015022475A8 (pt) | 2019-11-26 |
SI2968467T1 (sl) | 2020-11-30 |
PL2968467T3 (pl) | 2020-10-19 |
JP2016513667A (ja) | 2016-05-16 |
KR102238379B1 (ko) | 2021-04-09 |
MX370416B (es) | 2019-12-10 |
KR20150130396A (ko) | 2015-11-23 |
CA2904169A1 (en) | 2014-10-02 |
RU2707550C2 (ru) | 2019-11-27 |
CA2904169C (en) | 2021-12-07 |
HUE049707T2 (hu) | 2020-11-30 |
HRP20201161T1 (hr) | 2020-11-13 |
EP2968467A1 (en) | 2016-01-20 |
KR102317151B1 (ko) | 2021-10-26 |
BR112015022475A2 (pt) | 2017-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201906057B (en) | Formulations with reduced oxidation | |
HK1212613A1 (zh) | 具有降低的氧化的配製物 | |
FR3006896B1 (fr) | Composition photoprotectrice | |
UA27947S (uk) | Підшипник | |
UA27946S (uk) | Підшипник | |
UA27945S (uk) | Підшипник | |
UA27939S (uk) | Підшипник | |
UA27887S (uk) | Підшипник | |
UA27896S (uk) | Підшипник | |
UA27898S (uk) | Підшипник | |
UA27894S (uk) | Підшипник | |
UA27897S (uk) | Підшипник | |
UA27596S (uk) | Підшипник | |
UA27344S (uk) | Підшипник | |
UA28267S (uk) | Підшипник | |
UA27346S (uk) | Підшипник | |
UA27497S (uk) | Підшипник | |
UA27343S (uk) | Підшипник | |
UA27342S (uk) | Підшипник | |
UA26020S (uk) | Підшипник | |
UA25240S (uk) | Підшипник | |
UA25241S (uk) | Підшипник | |
UA25661S (uk) | Підшипник | |
UA25546S (uk) | Підшипник | |
UA25467S (uk) | Підшипник |